CoChat

Clinical effects of probiotics are associated with increased interferon‐γ responses in very young children with atopic dermatitis

Prescott, S. L., Dunstan, J. A., Hale, J., Breckler, L., Lehmann, H., Weston, S., Richmond, P. · 2005 · Clinical & Experimental Allergy
Cited by 146

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Summary: Background We recently demonstrated that administration of probiotics resulted in significant clinical improvement in very young children with moderate‐to‐severe atopic dermatitis (AD). The purpose of this study was to determine the underlying immunological effects that are associated with these apparent clinical benefits. Methods Peripheral blood mononuclear cells (PBMC) were isolated from children (n=53) at baseline and at the end of an 8‐week supplementation period during which they received a probiotic (Lactobacillus fermentum PCC™) (n=26) or a placebo (n=27). A further sample was collected at 16 weeks (8 weeks after ceasing the supplement). Cytokine (IL‐5, IL‐6, IL‐10, IL‐13, IFN‐γ and TNF‐α) responses to allergens (egg ovalbumin (OVA), beta lactoglobulin (BLG), house dust mite (HDM)), vaccines (tetanus toxoid (TT)), diphtheria toxoid (DT)), intestinal flora (heat‐killed Lactobacillus (HKLB)), heat‐killed Staphylococcus aureus (HKSA), Staphylococcus aureus enterotoxin B (SEB) and mitogen (phytohaemaglutinin (PHA)) were compared. Results The administration of probiotics was associated with a significant increase in T‐helper type 1(Th1‐type) cytokine IFN‐γ responses to PHA and SEB at the end of the supplementation period (week 8: P=0.004 and 0.046) as well as 8 weeks after ceasing supplementation (week 16: P=0.005 and 0.021) relative to baseline levels of response. No significant changes were seen in the placebo group. The increase in IFN‐γ responses to SEB was directly proportional to the decrease in the severity of AD (r=−0.445, P=0.026) over the intervention period. At the end of the supplementation period (week 8) children receiving probiotics showed significantly higher TNF‐α responses to HKLB (P=0.018) and HKSA (P=0.011) but this was no longer evident when supplementation ceased (week 16). Although IL‐13 responses to OVA were significantly reduced in children receiving probiotics after 8 weeks (P=0.008), there were no other effects on allergen‐specific responses, and this effect was not sustained after ceasing supplementation (week 16). There were no effects on vaccine‐specific responses, or on responses to any of the stimuli assessed. Conclusion The improvement in AD severity with probiotic treatment was associated with significant increases in the capacity for Th1 IFN‐γ responses and altered responses to skin and enteric flora. This effect was still evident 2 months after the supplementation was ceased. The lack of consistent effects on allergen‐specific responses suggests that the effects of probiotics may be mediated through other independent pathways, which need to be explored further.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2222.2005.02376.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 146

Metadata

Authors
Prescott, S. L., Dunstan, J. A., Hale, J., Breckler, L., Lehmann, H., Weston, S., & Richmond, P.
Venue
Clinical & Experimental Allergy
Publisher
Wiley
Published
2005-12
Volume
35
Issue
12
Pages
1557-1564
ISSN
  • 0954-7894 (ISSN-L)
  • 1365-2222
OpenAlex
W1941442833
Cited by
146
References
2
FWCI
21.42
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical effects of probiotics are associated with increased interferon‐γ responses in very young children with atopic dermatitis. https://app.cochat.ai/papers/10.1111/j.1365-2222.2005.02376.x
The paper
Prescott, S. L., Dunstan, J. A., Hale, J., Breckler, L., Lehmann, H., Weston, S., & Richmond, P. (2005). Clinical effects of probiotics are associated with increased interferon‐γ responses in very young children with atopic dermatitis. Clinical & Experimental Allergy. https://doi.org/10.1111/j.1365-2222.2005.02376.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.